High rates of adrenal pathology, especially CYP11B2-positive findings and possibly pheochromocytomas, could have implications for the prevention of sudden death, as low-cost biochemical screening for primary aldosteronism and pheochromocytoma is available. The gene discussed is CYP11B2; the disease is pheochromocytoma.